Overview Cumulus Neuroscience published final CNS-102 results showing that its at-home NeuLogiq platform is feasible and well tolerated in people with ALS and FTD. The platform combines at-home EEG wi...
Overview Lumos Labs has received FDA 510(k) clearance for LumosityRx, a prescription digital therapeutic (PDT) designed to improve attention in adults aged 22 to 55 with ADHD. Built o...
